IRIS
PUGLISI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.914
AS - Asia 11.907
EU - Europa 6.724
SA - Sud America 2.131
Continente sconosciuto - Info sul continente non disponibili 1.343
AF - Africa 260
OC - Oceania 16
Totale 47.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.491
SG - Singapore 5.736
CN - Cina 2.268
BR - Brasile 1.709
UA - Ucraina 1.278
IT - Italia 1.199
HK - Hong Kong 1.170
VN - Vietnam 1.052
DE - Germania 951
RU - Federazione Russa 592
FI - Finlandia 581
FR - Francia 512
SE - Svezia 355
IN - India 351
BD - Bangladesh 339
GB - Regno Unito 319
IE - Irlanda 318
CA - Canada 239
TR - Turchia 200
AR - Argentina 150
KR - Corea 149
NL - Olanda 97
MX - Messico 92
PL - Polonia 87
JP - Giappone 85
AT - Austria 82
IQ - Iraq 76
ID - Indonesia 68
EC - Ecuador 67
ZA - Sudafrica 66
BE - Belgio 58
CO - Colombia 57
ES - Italia 57
PK - Pakistan 57
CZ - Repubblica Ceca 44
VE - Venezuela 41
CH - Svizzera 39
SA - Arabia Saudita 38
MA - Marocco 34
UZ - Uzbekistan 34
RO - Romania 32
IR - Iran 31
TG - Togo 30
CL - Cile 29
AE - Emirati Arabi Uniti 27
PY - Paraguay 26
TN - Tunisia 24
PH - Filippine 23
LT - Lituania 22
PE - Perù 22
EG - Egitto 20
JM - Giamaica 20
DZ - Algeria 19
NP - Nepal 19
UY - Uruguay 18
KE - Kenya 17
EU - Europa 16
GR - Grecia 15
IL - Israele 15
OM - Oman 15
AU - Australia 14
TH - Thailandia 14
KZ - Kazakistan 13
AL - Albania 12
AZ - Azerbaigian 12
BO - Bolivia 12
JO - Giordania 12
MY - Malesia 12
KG - Kirghizistan 10
LB - Libano 10
AM - Armenia 9
CR - Costa Rica 9
EE - Estonia 9
ET - Etiopia 9
LV - Lettonia 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
HN - Honduras 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
BY - Bielorussia 7
RS - Serbia 7
TW - Taiwan 7
PA - Panama 6
SV - El Salvador 6
BB - Barbados 5
BH - Bahrain 5
DK - Danimarca 5
KH - Cambogia 5
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
MN - Mongolia 5
QA - Qatar 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
CI - Costa d'Avorio 4
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
Totale 45.887
Salva come PNG Salva come JPEG
Città #
Fairfield 2.561
Singapore 2.328
Ashburn 2.316
Woodbridge 1.761
Houston 1.288
Hong Kong 1.158
Chandler 1.120
Seattle 1.015
Ann Arbor 1.010
San Jose 998
Beijing 965
Wilmington 932
Cambridge 854
Jacksonville 820
Council Bluffs 707
Dearborn 547
Boardman 545
Los Angeles 534
Chicago 452
Lauterbourg 384
Ho Chi Minh City 319
Dublin 309
Princeton 299
New York 271
Hanoi 216
Dallas 207
Buffalo 204
Santa Clara 203
Udine 192
Hefei 186
Salt Lake City 173
Helsinki 165
Munich 158
São Paulo 157
Dong Ket 145
San Diego 144
The Dalles 144
Redondo Beach 136
Seoul 133
Izmir 126
Elk Grove Village 94
Tampa 90
Ogden 85
Des Moines 84
Frankfurt am Main 84
Milan 83
Tokyo 80
Nuremberg 78
Warsaw 73
Montreal 64
Orem 61
Brooklyn 58
Phoenix 58
Rome 56
Ottawa 55
Denver 53
Brussels 52
Lancaster 52
London 51
Guangzhou 50
Norwalk 50
Turku 47
Miami 46
Stockholm 46
Chennai 45
Mumbai 45
Nanjing 45
Sterling 44
Kunming 42
Trieste 42
Washington 42
Mexico City 39
Rio de Janeiro 39
Toronto 39
Atlanta 38
Baghdad 38
Belo Horizonte 38
Poplar 38
Amsterdam 37
Codroipo 36
Da Nang 36
Johannesburg 36
Lappeenranta 34
San Francisco 34
Vienna 33
Detroit 32
Manchester 32
Curitiba 30
Lomé 30
Tashkent 30
Brno 29
Redmond 29
Shanghai 29
Hyderabad 28
Zurich 28
Boston 27
Brasília 27
Jinan 27
Paris 27
Biên Hòa 26
Totale 28.983
Salva come PNG Salva come JPEG
Nome #
Risks in Oncology and Radiation Therapy 685
Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype 684
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests 482
Hepatitis B and cancer: A practical guide for the oncologist 266
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 231
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis 227
Bone scanning in lung cancer [2] (multiple letters) 226
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 222
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects 221
Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making? 206
Expression of periostin in human breast cancer 205
Role of pre-surgical breast MRI in the management of invasive breast carcinoma 204
Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis 198
First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma 197
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 195
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 192
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme 191
Pattern of metastasis and outcome in patients with breast cancer 189
Galectin-3 expression in non-small cell lung carcinoma 187
Bevacizumab in older patients with advanced colorectal or breast cancer 186
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy 184
Neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios in breast cancer 184
Role of mammography, ultrasound and large-core biopsy in the diagnostic evaluation of papillary breast lesions 182
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 182
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 181
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 181
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 180
Molecular diagnosis of neoplasms 175
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme 175
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 175
Bone scanning in lung cancer: pretest probability is of value 173
B-cell lymphoma presenting as acute pancreatitis 173
D-dimer and venous thromboembolism 171
Gene expression profiling in breast cancer: a clinical perspective. 171
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. 171
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study 171
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 169
Measures of outcome in metastatic breast cancer: insights from a real-world scenario. 169
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer 169
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. 168
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 168
Primary therapy in breast cancer: what have we learned from landmark trials? 167
Taxane-induced nail changes: incidence, clinical presentation and outcome 166
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example 166
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 165
Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy 165
What does similarity mean in clinical trials? 163
Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM) 163
Sonographic criteria for differentiation of benign and malignant solid breast lesions: size is of value 162
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy 161
LOCALLY ADVANCED BREAST CANCER: COMPARISON OF MAMMOGRAPHY, SONOGRAPHY AND MR IMAGING IN EVALUATION OF RESIDUAL DISEASE IN WOMEN RECEIVING NEOADJUVANT CHEMOTHERAPY 161
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics 159
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 159
Treatment of metastatic breast cancer in a real-world scenario: Is progression-free survival with first line predictive of benefit from second and later lines? 158
Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story? 158
TSH controls ref-1 nuclear translocation in thyroid cells 156
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients 156
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer 155
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly 155
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 155
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 154
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer 154
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 154
Predictors of axillary lymph node metastases in patients with T1 breast carcinoma 153
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 153
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer 152
Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology 151
Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study 151
[Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process?] 151
Do platinum salts fit all triple negative breast cancers? 151
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 150
p53 protein expression and p53 mutation in thymic epithelial tumors 149
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients 149
Prognostic evaluation in palliative care: final results from a prospective cohort study 149
Angiogenesis and tumor growth 148
Expert pathology consultation through the Internet: melanoma versus benign melanocytic tumours 148
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? 148
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 148
Information to cancer patients: a questionnaire survey in three different geographical areas in Italy. 147
Looking for predictive markers in breast cancer 147
Capecitabine-induced cardiotoxicity: More evidence or clinical approaches to protect the patients' heart? 147
Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas 146
PROTEOMIC EVALUATION OF CORE BIOPSY SPECIMENS FROM BREAST LESIONS 146
Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly? 146
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 146
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 146
Treatment of HER2-positive breast cancer: current status and future perspectives 145
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial 145
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors 144
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index 144
CDK 4/6 inhibitors as single agent in advanced solid tumors 144
Atypical ductal hyperplasia of the breast. Its diagnostic imaging and the role of percutaneous needle biopsy with a 14-gauge needle 143
Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole 143
Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma. 142
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey 142
Sequential chemotherapy with Paclitaxel plus Cisplatin, followed by Vinorelbine, followed by Gemcitabine in advanced non-small cell lung cancer: an Alpe Adria Thoracic Oncology Multidisciplinary group study (ATOM 001) 141
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 141
Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM) 141
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma 141
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 141
Totale 17.997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 179.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.555 214 216 83 162 69 142 148 116 40 440 551 374
2022/20232.662 332 191 71 309 270 726 29 205 338 37 90 64
2023/20241.387 123 91 73 51 194 277 41 74 134 109 59 161
2024/20257.555 190 466 304 251 377 416 470 430 768 706 1.191 1.986
2025/202617.102 1.641 2.326 1.454 1.607 2.241 1.204 1.746 607 1.143 1.263 1.174 696
2026/2027475 475 0 0 0 0 0 0 0 0 0 0 0
Totale 47.295